Improving Regulatory Transparency for New Medical Therapies Act
Official title: “To amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing.”
What this law changes
Not startedPlain-language account: Not started
Transparency Score
The Transparency Score is the share of this law’s dollars that goes to what the law says it is for. We have not read this law for this section yet.
What this law changes in taxes
We have not read this law for this section yet.
Press releases by members of Congress
No saved press release names this law.
Read from 539 of 539 members' sites, releases since January 3, 2025, through October 8, 2026.
Press releases by organizations
No saved press release from these organizations names this law.
Read from 510 of 510 organizations' sites, releases since January 3, 2025, through October 8, 2026.
How it passed
The Senate passed it without objection on October 26, 2015. No individual votes are recorded.
The House passed it without objection on November 16, 2015. No individual votes are recorded.
It became law on November 25, 2015.
How each member votes
Both chambers passed this law without a recorded vote, so no individual votes exist.
Where this comes from
A file marked "saved" is our own copy of the official file. The code beside it is its fingerprint, a short code that changes if the file's contents change. A file with no copy saved carries "Not published yet".